| MAP2K4 |
MAP2K4, JNKK1, MKK4, PRKMK4, SERK1: Dual specificity mitogen-activated protein k |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| S100A9 |
S100A9, CAGB, CFAG, MRP14: Protein S100-A9 |
TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
0.265 |
Evidence |
|
| PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
LAMA2 |
LAMA2: Uncharacterized protein LAMA2 |
0.265 |
Evidence |
|
| SFRS15 |
SFRS15, KIAA1172: Splicing factor, arginine/serine-rich 15 |
RBM3 |
RBM3, RNPL: Putative RNA-binding protein 3 |
0.265 |
Evidence |
|
| EIF5AP1 |
EIF5A: Eukaryotic translation initiation factor 5A-1 |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
0.265 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
ICOSLG |
ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653: ICOS ligand precursor |
0.265 |
Evidence |
|
| APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
FNBP1 |
IPI00102670 |
0.265 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
0.265 |
Evidence |
|
| C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
ALB |
ALB: Uncharacterized protein ALB |
0.265 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
PRPF4B |
PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol |
0.265 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
0.265 |
Evidence |
|
| CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
IGFBP6 |
IGFBP6, IBP6: Insulin-like growth factor-binding protein 6 precursor |
0.265 |
Evidence |
|
| SNAPC4 |
SNAPC4, SNAP190: snRNA-activating protein complex subunit 4 |
TGIF2 |
TGIF2: Homeobox protein TGIF2 |
0.265 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
CDK4 |
CDK4: Cell division protein kinase 4 |
0.265 |
Evidence |
|
| SRPK2 |
SRPK2: Serine/threonine-protein kinase SRPK2 |
JAK1 |
|
0.265 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| CFHR2 |
CFHR2, CFHL2, FHR2, HFL3: Complement factor H-related protein 2 precursor |
SERPINA3 |
IPI00550991 |
0.265 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
0.265 |
Evidence |
|
| ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
0.265 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
CIB1 |
CIB1, CIB, KIP, PRKDCIP: Calcium and integrin-binding protein 1 |
0.265 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
0.265 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
0.265 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
DYNC1LI1 |
DYNC1LI1, DNCLI1: Cytoplasmic dynein 1 light intermediate chain 1 |
0.265 |
Evidence |
|
- 
- 
-